L'Hôpital Général de Référence de Tunda
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MBALA, Placide
NCT05734508: Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC

Completed
4
500
RoW
MVA-BN vaccine, JYNNEOS
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Monkeypox
06/24
06/24
EBO-PEP, NCT06841614: EBOla Post-Exposure Prophylaxis

Not yet recruiting
3
160
RoW
Ervebo, r-VSV-ZEBOV vaccine, Inmazeb, REGN-EB3
ANRS, Emerging Infectious Diseases, Alliance for International Medical Action, Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Medecins Sans Frontieres, Netherlands, Barcelona Institute for Global Health, University of Bordeaux, INSERM 1136, Agence Nationale de Sécurité Sanitaire de Guinée (ANSS), National Institute for Biomedical Research DRC, Cheikh Anta Diop University, Senegal, PACCI Program, The PANdemic preparedness plaTform for Health and Emerging infectious Response, University of Sierra Leone College of Medicine and Allied Health Sciences, National Public Health Institute of Liberia
Ebola Virus Disease
06/27
12/27
NCT05559099: Tecovirimat for Treatment of Monkeypox Virus

Completed
2
597
RoW
Tecovirimat Oral Capsule, TPOXX, Placebo
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Monkeypox
09/24
09/24
NCT06721585: Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

Recruiting
N/A
400
RoW
Tecovirimat Oral Capsule [Tpoxx], TPOXX, Standard of Care (SOC)
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Mpox (Monkeypox)
07/25
07/25
DiagRaMIE Mpox, NCT06840197: Virus-RDC for the Diagnostic of Monkeypox

Not yet recruiting
N/A
197
RoW
NG-TestⓇ Monkeypox virus kit
Assistance Publique - Hôpitaux de Paris, NG Biotech, Commissariat A L'energie Atomique
Mpox (Monkeypox), Monkeypox Virus Infection
05/25
05/25
Alonga, Jules
NCT05559099: Tecovirimat for Treatment of Monkeypox Virus

Completed
2
597
RoW
Tecovirimat Oral Capsule, TPOXX, Placebo
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Monkeypox
09/24
09/24
NCT06721585: Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

Recruiting
N/A
400
RoW
Tecovirimat Oral Capsule [Tpoxx], TPOXX, Standard of Care (SOC)
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Mpox (Monkeypox)
07/25
07/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MBALA, Placide
NCT05734508: Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC

Completed
4
500
RoW
MVA-BN vaccine, JYNNEOS
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Monkeypox
06/24
06/24
EBO-PEP, NCT06841614: EBOla Post-Exposure Prophylaxis

Not yet recruiting
3
160
RoW
Ervebo, r-VSV-ZEBOV vaccine, Inmazeb, REGN-EB3
ANRS, Emerging Infectious Diseases, Alliance for International Medical Action, Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Medecins Sans Frontieres, Netherlands, Barcelona Institute for Global Health, University of Bordeaux, INSERM 1136, Agence Nationale de Sécurité Sanitaire de Guinée (ANSS), National Institute for Biomedical Research DRC, Cheikh Anta Diop University, Senegal, PACCI Program, The PANdemic preparedness plaTform for Health and Emerging infectious Response, University of Sierra Leone College of Medicine and Allied Health Sciences, National Public Health Institute of Liberia
Ebola Virus Disease
06/27
12/27
NCT05559099: Tecovirimat for Treatment of Monkeypox Virus

Completed
2
597
RoW
Tecovirimat Oral Capsule, TPOXX, Placebo
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Monkeypox
09/24
09/24
NCT06721585: Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

Recruiting
N/A
400
RoW
Tecovirimat Oral Capsule [Tpoxx], TPOXX, Standard of Care (SOC)
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Mpox (Monkeypox)
07/25
07/25
DiagRaMIE Mpox, NCT06840197: Virus-RDC for the Diagnostic of Monkeypox

Not yet recruiting
N/A
197
RoW
NG-TestⓇ Monkeypox virus kit
Assistance Publique - Hôpitaux de Paris, NG Biotech, Commissariat A L'energie Atomique
Mpox (Monkeypox), Monkeypox Virus Infection
05/25
05/25
Alonga, Jules
NCT05559099: Tecovirimat for Treatment of Monkeypox Virus

Completed
2
597
RoW
Tecovirimat Oral Capsule, TPOXX, Placebo
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Monkeypox
09/24
09/24
NCT06721585: Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

Recruiting
N/A
400
RoW
Tecovirimat Oral Capsule [Tpoxx], TPOXX, Standard of Care (SOC)
National Institute of Allergy and Infectious Diseases (NIAID), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Mpox (Monkeypox)
07/25
07/25

Download Options